Start with what you know right now, even before every detail is final. Leaders should talk with finance and adjacent teams to separate decisions that need certainty from the work that holds value ...

IRVING, Texas, October 21, 2026 — The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 94 cents per share of common stock. The dividend will be payable on ...

October is American Pharmacists Month, a time to recognize and celebrate pharmacists for the incredible impact they make every day across healthcare. It also includes Women Pharmacist Day and National ...

Learn how Health Mart Atlas helps community pharmacies navigate payer contracts, reimbursement and administrative complexity to stay focused on patient care.

See how Ontada’s ON.Journey delivers research-grade, longitudinal community oncology data to help life sciences teams generate real-world evidence.

NEW YORK, IRVING, Texas and BANNOCKBURN, Ill., October 6, 2026 — CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today ...

IRVING, Texas, October 1, 2026—McKesson Corporation (NYSE: MCK) announced today that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to ...

McKesson is investigating a cybersecurity incident involving third-party applications and unauthorized access and exfiltration of data. McKesson supplies medical equipment, pharmaceuticals, and health ...

IRVING, Texas, August 25, 2026—McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire Precision Medicine Group, LLC (“Precision Medicine Group”), a global ...

IRVING, Texas, August 5, 2026 - McKesson Corporation (NYSE:MCK) today announced results for the first quarter ended June 30, 2026. Consolidated revenues of $105.4 billion increased 8%. Earnings per ...

Distributing one-third of medicines with more than 99% inventory and order accuracy, strengthening advanced cancer care for patients through support of approximately 3,300 independent oncology ...

As specialty medications continue to dominate new therapy approvals and overall drug spend, the performance of the specialty pharmacy becomes increasingly consequential. Specialty pharmacy success is ...